REMSleep Holdings, Inc. (RMSL)
| Market Cap | 15.24M |
| Revenue (ttm) | 117.19K |
| Net Income (ttm) | -1.08M |
| Shares Out | 1.52B |
| EPS (ttm) | -0.00 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 812,553 |
| Average Volume | 1,098,993 |
| Open | 0.0090 |
| Previous Close | 0.0092 |
| Day's Range | 0.0090 - 0.0100 |
| 52-Week Range | 0.0051 - 0.0265 |
| Beta | 0.67 |
| RSI | 45.43 |
| Earnings Date | Apr 16, 2025 |
About REMSleep Holdings
REMSleep Holdings, Inc. focuses on the development and distribution of products to help people affected by sleep apnea worldwide. The company offers DeltaWave CPAP interface device to treat patients with sleep apnea. It serves sleep product distributors, home care dealers, private sleep labs, product end users, sleep physicians, medical group, and hospitals, as well as medical associations. The company is headquartered in Clearwater, Florida. [Read more]
Financial Performance
In 2024, REMSleep Holdings's revenue was $117,185, a decrease of -42.48% compared to the previous year's $203,718. Losses were -$1.08 million, -39.36% less than in 2023.
Financial StatementsNews
REMSleep Holdings, Inc. Shareholder Update
CLEARWATER, Fla., Nov. 15, 2024 (GLOBE NEWSWIRE) -- REMSleep Holdings, Inc. (OTCQB: RMSL): To all stockholders, this is an update as to the status of the launch of the Deltawave product to the marketp...
REMSleep Patent Application Has Been Allowed by the United States Patent and Trademark Office
CLEARWATER, FL, Sept. 03, 2024 (GLOBE NEWSWIRE) -- REMSleep Holdings, Inc. (OTCQB: RMSL) announces that another utility patent for its Nasal Ventilation System has been allowed by the United States Pa...
REMSleep Holdings Patent Status
CLEARWATER, FL, March 06, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire - REMSleep Holdings, Inc. (OTCQB: RMSL) is awarded new patent.
REMSleep Holdings Shareholder Update
CLEARWATER, FL, March 04, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire - REMSleep Holdings, Inc. (OTC PINK: RMSL) gives an update on FDA process and REMSleep status. We have had numerous inquiries asking...
RemSleep Holdings Inc. Engages New Senior Director for Regulatory Compliance and New Regulatory Testing Company
Tampa, FL, July 22, 2022 (GLOBE NEWSWIRE) -- RemSleep Holdings Inc. (OTC Pink: RMSL), a medical device manufacturer dedicated to forever improving the level of treatment provided to obstructive Sleep ...
RemSleep Holdings Inc. Announces 510(k) Submission for DeltaWave
Tampa, FL, May 06, 2022 (GLOBE NEWSWIRE) -- RemSleep Holdings Inc (OTC PINK: RMSL), a medical device manufacturer dedicated to forever changing the level of treatment provided to obstructive sleep apn...
Condensation Testing Per ISO 18562-4:2017
Tampa, FL, Jan. 05, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- REMSleep Holdings, Inc. (OTC PINK: RMSL): The company announces that testing for ISO 18562-4:2017 has been completed. We are actively c...
REMSleep Announces Condensation Testing per ISO 18562-4 :2017
Tampa, FL, Nov. 10, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- REMSleep Holdings, Inc. (OTC PINK: RMSL): The company has engaged testing company to complete the condensation testing per ISO 18562-4...